Crown Laboratories, Revance Enter Merger Agreement

By Karen Roman Private skincare company Crown Laboratories, Inc. and biotechnology company Revance Therapeutics, Inc. (NASDAQ: RVNC), made public their merger agreement to become a new combined company. Crown plans to acquire all outstanding shares of Revance’s common stock for...